The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
PIPETTE 4R Tau and Alpha-Synuclein PET Tracer Development, 2021Development of Selective Markers for Imaging Abnormal Protein Aggregates in Parkinson’s Disease
Study Rationale:
In neurological disorders such as Parkinson’s disease (PD) or frontotemporal dementia, the proteins alpha-synuclein or tau are structurally altered and accumulate in clumps in the... -
Target Advancement Program, 2021Pre-clinical Validation of a Novel Target for Dyskinesia Induced by Levodopa
Study Rationale:
The motor symptoms associated with Parkinson’s disease (PD) are treated by replacing dopamine, the brain chemical that is lost when dopamine-producing neurons die. Initially... -
Research Grant, 2021Developing a Diagnostic Test to Detect the Signature Scent of Parkinson’s Disease
Study Rationale:
People with Parkinson’s disease (PD) emit a novel odor that can be detected months to years before the onset of symptoms. The molecules responsible for this characteristic scent are... -
Research Grant, 2021Bipolar Disorder and Parkinson’s Disease
Study Rationale:
Mood disorders are common in people with Parkinson’s disease (PD) and, in many cases, precede motor symptoms and diagnosis by years. The relationship between bipolar disorder and PD... -
Target Advancement Program, 2021Targeting the Body’s Circadian Clock to Improve Sleep Quality in Parkinson’s Disease
Study Rationale:
Chronic sleep disruption is among the most frequently reported and disabling pathological features of Parkinson’s disease (PD). This loss of sleep quality is driven by dysregulation... -
Target Advancement Program, 2021Sex-based Modulation of Neuromelanin-linked Parkinson’s Disease Pathology
Study Rationale:
Parkinson’s disease (PD) is more common in men than in women, and men with PD exhibit earlier onset, faster progression, more severe motor symptoms and more frequent cognitive decline...
![Two female doctors talking in the lab.](/sites/default/files/styles/ad_callout_single/public/images/ad/apply-for-grant-404-Large-Image-Callout-A-1.jpg?h=2a1ad497&itok=-_5jZ5iX)
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.